One of the listed companies, Indo-Bangla Pharmaceuticals Limited discloses its financial reports for the second quarter, (October – December 23).
The company’s earnings per share (EPS) loss Tk 0.06 paisa in Q2 of the current financial year (October – December 23). EPS was loss Tk 0.08 paisa during the same period last year. NAV per share was Tk. 113.91 as of December 31, 2023.
Share this
